Search Results

Your search for Gregory Bociek, MD, MSc,Gregory Bociek, MD, MSc matches 2 pages

Showing 1 - 2

By VIJAYA RAJ BHATT, MBBS, MS, AND R. GREGORY BOCIEK, MD, MSc / February 25, 2023 - Supplement: Conference Highlights ASH 2022 / 2022 ASH Annual Meeting and Exposition

Highlights From the 2022 ASH Annual Meeting and Exposition

The 2022 American Society of Hematology (ASH) Annual Meeting and Exposition took place in the vibrant city of New Orleans. The meeting brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from hypothesis-generating to...

leukemia

By Gregory Bociek, MD, MSc / October 25, 2021

BTK Inhibition in CLL: An Embarrassment of Riches

Chronic lymphocytic leukemia (CLL) is a B-cell lymphoproliferative disorder defined by a specific phenotype and the presence of more than 5,000 clonal B cells in the peripheral blood.1 In the absence of this number of circulating cells, its soft-tissue/bone-marrow counterpart is semantically...

Nov

Today In Oncology

Search Results

Your search for Gregory Bociek, MD, MSc,Gregory Bociek, MD, MSc matches 2 pages

Highlights From the 2022 ASH Annual Meeting and Exposition

BTK Inhibition in CLL: An Embarrassment of Riches

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC